SR-318
SR-318, a chemical probe, is a potent and highly selective p38 MAPK inhibitor with IC50s of 5 nM, 32 nM and 6.11 μM for p38α, p38β and p38α/β, respectively. SR-318 potently inhibits the TNF-α release in whole blood with an IC50 of 283 nM. SR-318 has anti-cancer and anti-inflammatory activity[1].
Product Specifications
CAS Number
2413286-32-3
UNSPSC
12352005
Target
P38 MAPK; TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sr-318.html
Concentration
10mM
Purity
98.17
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=C(N)N(C2=CC=CC=C2)N=C1)NCC3=CC=C(C(NCCCC4CCCCC4)=O)C=C3
Molecular Formula
C27H33N5O2
Molecular Weight
459.58
References & Citations
[1]Röhm S, et al. Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors. J Med Chem. 2019 Dec 12;62 (23) :10757-10782.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
P38α; p38β; TNFRSF5/CD40
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742206-500 1x 500 µL
HSP60 (Heat Shock Protein 60) (Mitochondrial Marker) (HSPD1/2206R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC434048 20 µg
APRIL (TNFSF13) (NM_001198624) Human Over-expression Lysate
Sign In for Pricing
View Details 
